EMN for Traceability in Laboratory Medicine

Laboratory testing is at the heart of modern health care: an estimated 70% of medical decisions depend on in vitro diagnostics (IVDs). Benefits for patients, healthcare providers and the IVD industry are improved when robust and metrologically traceable IVDs are used to provide accurate test results irrespective of the laboratory, the IVD provider, or the instrumentation used for testing.

Metrological traceability of IVDs enhances validity of diagnosis, supports further treatment, and lowers the financial burden on healthcare systems by avoiding nonessential testing. Traceability is also an important aspect of regulatory schemes: IVD manufacturers need to comply with legal requirements for traceability to gain and maintain market access.

These requirements are defined in the regulation on in vitro diagnostic medical devices EU 2017/746 (IVDR) and include metrological traceability of calibrator and control material values along with testing of highrisk IVDs by EU reference laboratories. The European network on Traceability in Laboratory Medicine (TraceLabMed) was established to build a coordinated metrologybased quality infrastructure in an area that affects almost every European citizen.

For download: Overview of EMN TraceLabMed (PDF)

EMN Chair

Rainer Stosch, PTB, Germany

TLM News

See all EURAMET news
EMPIR project on biological research helps support COVID-19 response
A recently completed EMPIR project has helped develop 3 standards about the counting of biological entities important for diagnosing respiratory infec...
EMN for Traceability in Laboratory Medicine has 1st meeting with Stakeholders
19 - 21 June 2019 in PTB, Braunschweig The European Metrology Network for Traceability in Laboratory Medicine has its first meeting with participatin...
New EURAMET Traceability in Laboratory Medicine EMN to give talk at CIM 2019
International Metrology Congress: 24 – 26 September 2019, Paris, France